Updates from The Motley Fool

Latest updates on GlaxoSmithKline from Fool.com.


Stock Performance

GSK vs. S&P 500 | 2 Year Performance
GSK 1-Day Stock Chart
GSK 5-Day Stock Chart
GSK 1-Month Stock Chart
GSK 3-Month Stock Chart
GSK 6-Month Stock Chart
GSK 1-Year Stock Chart
GSK 2-Year Stock Chart
GSK 5-Year Stock Chart
View Interactive GSK Charts
Sponsored by

Key Data Points

Primary metrics and data points about GlaxoSmithKline.
Current Price: $42.91
Prev Close: $43.36
Open: $43.21
Bid: $42.52
Ask: $42.95
Day's Range: $42.68 - $43.33
52wk Range: $37.24 - $46.76
Volume: 3,023,649
Avg Vol 3,428,092
Market Cap: $104.48B
P/E (ttm): 24.92
EPS (ttm): $1.74
Div & Yield: $2.33 (5.3%)

Company Rating

What our community thinks about GlaxoSmithKline.
CAPS Rating 4 out of 5
 
1420 Outperform
81 Underperform
CAPS All Stars
 
357 Outperform
21 Underperform

How do you think GlaxoSmithKline will perform against the market?



You pick for GlaxoSmithKline is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Andrew Witty, CEO

66% Approve

Based on 596 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for GlaxoSmithKline.

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers